EA201390626A1 - Производные гидроксамовой кислоты и применение указанных производных в лечении бактериальных инфекций - Google Patents

Производные гидроксамовой кислоты и применение указанных производных в лечении бактериальных инфекций

Info

Publication number
EA201390626A1
EA201390626A1 EA201390626A EA201390626A EA201390626A1 EA 201390626 A1 EA201390626 A1 EA 201390626A1 EA 201390626 A EA201390626 A EA 201390626A EA 201390626 A EA201390626 A EA 201390626A EA 201390626 A1 EA201390626 A1 EA 201390626A1
Authority
EA
Eurasian Patent Office
Prior art keywords
derivatives
bacterial infections
treatment
application
hydroxamic acid
Prior art date
Application number
EA201390626A
Other languages
English (en)
Russian (ru)
Inventor
Рамеш Касар
Мартин Шерингэм Линселл
Джеймс Брэдли Эгжен
Цин Лу (Джейн)
Дэн Ван
Тим Черч
Хейнц Э. Моузер
Филип А. Пэттен
Original Assignee
Эйкеоджен, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эйкеоджен, Инк. filed Critical Эйкеоджен, Инк.
Publication of EA201390626A1 publication Critical patent/EA201390626A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EA201390626A 2010-11-10 2011-11-04 Производные гидроксамовой кислоты и применение указанных производных в лечении бактериальных инфекций EA201390626A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41231110P 2010-11-10 2010-11-10
PCT/US2011/059280 WO2012154204A1 (en) 2010-11-10 2011-11-04 Hydroxamic acid derivatives and their use in the treatment of bacterial infections

Publications (1)

Publication Number Publication Date
EA201390626A1 true EA201390626A1 (ru) 2013-12-30

Family

ID=46317476

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201390626A EA201390626A1 (ru) 2010-11-10 2011-11-04 Производные гидроксамовой кислоты и применение указанных производных в лечении бактериальных инфекций

Country Status (14)

Country Link
EP (1) EP2638006A1 (https=)
JP (1) JP2014501716A (https=)
KR (1) KR20140023869A (https=)
CN (1) CN103298780A (https=)
AR (1) AR083760A1 (https=)
AU (1) AU2011367819A1 (https=)
BR (1) BR112013011693A2 (https=)
CA (1) CA2817211A1 (https=)
EA (1) EA201390626A1 (https=)
IL (1) IL226270A0 (https=)
MX (1) MX2013005200A (https=)
SG (1) SG190243A1 (https=)
TW (1) TW201249786A (https=)
WO (1) WO2012154204A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI519508B (zh) 2007-06-12 2016-02-01 Achaogen Inc 抗菌劑
EP2847162A1 (en) * 2012-05-09 2015-03-18 Achaogen, Inc. Antibacterial agents
EP2847168A1 (en) 2012-05-10 2015-03-18 Achaogen, Inc. Antibacterial agents
AR097617A1 (es) 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
EA030730B1 (ru) 2013-12-19 2018-09-28 Идорсиа Фармасьютиклз Лтд Антибактериальные производные 1h-индазола и 1h-индола
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
US9539305B1 (en) 2014-03-14 2017-01-10 Fleurir Abx Llc Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
CA2948077A1 (en) 2014-05-16 2015-11-19 Actelion Pharmaceuticals Ltd Antibacterial quinazoline-4(3h)-one derivatives
KR20170086079A (ko) 2014-11-19 2017-07-25 액테리온 파마슈티칼 리미티드 항균성 벤조티아졸 유도체
DK3233843T3 (da) 2014-12-16 2019-11-18 Novartis Ag Isoxazol-hydraxamsyreforbindelser som LPXC-hæmmere
EP4286001A3 (en) 2016-04-25 2024-07-17 Duke University Benzoylglycine derivatives and methods of making and using same
JP6941630B2 (ja) 2016-06-14 2021-09-29 ノバルティス アーゲー 抗菌剤としての(r)−4(5−(シクロプロピルエチニル)イソオキサゾール−3−イル)−n−ヒドロキシ−2−メチル−2−(メチルスルホニル)ブタンアミドの結晶形
AR108864A1 (es) 2016-06-23 2018-10-03 Achaogen Inc Agentes antibacterianos
BR112020016270A2 (pt) * 2018-02-10 2020-12-15 Kbp Biosciences Co., Ltd. Composto atuando como antibióticos
CN110563611B (zh) * 2019-09-19 2021-02-02 中国医学科学院医药生物技术研究所 一种异羟肟酸类衍生物及其制备方法和应用
CN113957098A (zh) * 2021-09-13 2022-01-21 湖南工业大学 普罗威登斯属细菌菌株在制备二价锰氧化剂中的应用
CN116730870B (zh) * 2023-08-08 2023-10-13 中国医学科学院医药生物技术研究所 异羟肟酸类化合物或其可药用盐、及其用途和制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925659A (en) 1996-05-07 1999-07-20 Merck & Co., Inc. Antibacterial agents
AU5426398A (en) 1996-10-28 1998-05-22 Versicor Inc Methods for solid-phase synthesis of hydroxylamine compounds and derivatives, and combinatorial libraries thereof
EP1169031A1 (en) 1999-04-09 2002-01-09 British Biotech Pharmaceuticals Limited Antimicrobial agents
KR101076018B1 (ko) * 2003-01-08 2011-10-21 유니버시티 오브 워싱톤 항균제
DE102006032709A1 (de) 2006-07-14 2008-01-17 BSH Bosch und Siemens Hausgeräte GmbH Luftschallgedämmte Lebensmittelmühle
CN101209974A (zh) * 2006-12-31 2008-07-02 天津药物研究院 异羟肟酸类衍生物及其用途
TWI519508B (zh) 2007-06-12 2016-02-01 Achaogen Inc 抗菌劑
WO2011005355A1 (en) * 2009-05-07 2011-01-13 Achaogen, Inc. Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria
WO2011132712A1 (ja) * 2010-04-20 2011-10-27 大正製薬株式会社 新規なヒドロキサム酸誘導体

Also Published As

Publication number Publication date
AU2011367819A1 (en) 2013-05-02
MX2013005200A (es) 2013-06-28
KR20140023869A (ko) 2014-02-27
CA2817211A1 (en) 2012-11-15
TW201249786A (en) 2012-12-16
BR112013011693A2 (pt) 2016-08-09
SG190243A1 (en) 2013-06-28
IL226270A0 (en) 2013-07-31
JP2014501716A (ja) 2014-01-23
EP2638006A1 (en) 2013-09-18
WO2012154204A1 (en) 2012-11-15
AR083760A1 (es) 2013-03-20
CN103298780A (zh) 2013-09-11

Similar Documents

Publication Publication Date Title
EA201390626A1 (ru) Производные гидроксамовой кислоты и применение указанных производных в лечении бактериальных инфекций
EA201490647A1 (ru) Производные бензотиазол-6-илуксусной кислоты и их применение для лечения вич-инфекции
EA201001368A1 (ru) Гетероциклические производные мочевины и способы их применения-211
EA201490228A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
EA201391568A1 (ru) Новые производные имидазола, подходящие для лечения артрита
EA201100613A1 (ru) Конденсированные, спироциклические гетероароматические соединения для лечения бактериальных инфекций
EA201490774A1 (ru) Новые производные оксазина и их применение при лечении заболевания
EA201891103A1 (ru) Композиции для лечения спинальной мышечной атрофии
EA201491060A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
EA201491672A1 (ru) Гетероциклильные соединения как ингибиторы mek
EA201270560A1 (ru) Спиропиперидиновые соединения и их фармацевтическое применение для лечения диабета
EA201201680A1 (ru) Морфолинопиримидины и их применение в терапии
EA201890236A1 (ru) Полициклические карбамоилпиридоновые соединения и их фармацевтическое применение
EA201500265A1 (ru) Ингибиторы репликации вирусов гриппа
EA201590371A1 (ru) 1,4-дизамещенные аналоги пиридазина и способы лечения связанных с дефицитом smn состояний
EA201592256A1 (ru) Производные имидазопирролидинона и их применение при лечении заболеваний
MY188960A (en) Cyclic boronic acid ester derivatives and therapeutic uses thereof
EA201100750A1 (ru) Замещенные диоксопиперидинилфталимидные производные
UA104489C2 (uk) Сполуки для лікування дисліпідемії та споріднених хвороб
NZ607580A (en) N-heteroaryl compounds
EA201491623A1 (ru) Замещенные пирролидин-2-карбоксамиды
EA201200472A1 (ru) Сульфонамиды в качестве ингибиторов белков семейства bcl-2, предназначенные для лечения рака
EA201101533A1 (ru) Гетероциклические соединения в качестве ингибиторов mek
EA201390984A1 (ru) Гетероциклические соединения, подходящие для лечения дислипидемии
EA201591362A1 (ru) Соединения и способы лечения бактериальных инфекций